ClinicalTrials.gg
Active, not recruitingNCT06297109Updated Jan 27, 2026

Maxillary Patient Specific Implants in Bimaxillary Orthognathic Surgery

An interventional study of Patient-specific implants and Conventional mini-plates in Retrognathia and Malocclusion, Angle Class II, sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Active, not recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by Esbjerg Hospital - University Hospital of Southern Denmark · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2023, registered Jan 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Orthognathic surgery is a type of jaw surgery where a surgeon cuts the bones of the upper and lower jaw and places them better. There are two ways they can put the bones in the correct place and keep them in place after the surgery. One way, called the "conventional method", is to use a 3D-printed guide called a splint to set the bones in the right place and then screw the bones together using metal plates that the surgeon bends into shape to fit during the surgery. Another way is to use a patient-specific implants (PSI) that has been 3D-printed in titanium beforehand that because of its unique shape both places and keeps all the bones in the correct place after they are screwed in. Both ways of doing it are golden standards, meaning they are already approved.

Measuring the accuracy of the surgery is done by comparing the positions of the bones after the surgery with the intended positions of those bones, according to the surgical plan. The closer the achieved position of each bone is to the intended position, the more accurate the result.

Measuring the stability of the surgery is done by comparing the positions of the bones after the surgery with the positions of the bones two years later. The less the position is changed, the more stable the result.

The goal of this clinical trial is to see how accurate and stable PSIs are in orthognathic surgery when the maxilla is split in 3 pieces, and to compare them with the conventional method in patients with overjet or overbite. The main questions it aims to answer are:

  • Does using PSIs provide accurate movements of the maxilla pieces?
  • Does using PSIs provide more accurate movements of the maxilla pieces than the conventional method?
  • Does using PSIs provide stable movements of the maxilla pieces after 2 years?
  • Does using PSIs provide more stable movements of the maxilla pieces than the conventional method?

Participants will get orthognathic surgery as part of their normal orthodontic treatment.

Investigators will compare the PSI and conventional groups to see if the PSIs are more accurate than the conventional method.

02

Conditions studied

  • Retrognathia
  • Malocclusion, Angle Class II

Keywords

  • Orthognathic Surgery
  • Computer-Assisted Surgery
  • Three-dimensional Imaging
  • Cone-Beam Computed Tomography
  • Virtual Surgical Planning
  • Maxillary Osteotomy
  • Mandibular Osteotomy
  • Genioplasty
  • Osteotomy, Le Fort
  • Patient-Specific Implants
  • Accuracy
  • Stability
03

In context

Retrognathia

62 studies on the registry are indexed under Retrognathia; 15 are open to participants now.

This study's planned enrollment of 60 is above the median of 34 across 52 interventional studies indexed under Retrognathia.

Browse Retrognathia studies →

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark is the lead sponsor of 50 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mandibular retrognathia
  • Occlusion class II
  • Three-piece Le Fort I osteotomy, as part of bimaxillary orthognathic surgery with or without genioplasty

Exclusion criteria

Exclusion Criteria:

  • Cleft lip
  • Craniofacial syndromes
  • Former trauma
  • Obstructive sleep apnea
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention

    Participants treated with patient-specific implants for Le Fort I osteotomy and genioplasty in bimaxillary orthognathic surgery.

    Device: Patient-specific implants

  • Active comparator
    Control

    Participants treated with conventional mini-plates for Le Fort I osteotomy and genioplasty in bimaxillary orthognathic surgery.

    Device: Conventional mini-plates

Interventions

  • DevicePatient-specific implants

    Application of patient-specific implants for Le Fort I osteotomy and genioplasty in bimaxillary orthognathic surgery.

  • DeviceConventional mini-plates

    Application of conventional mini-plates for Le Fort I osteotomy and genioplasty in bimaxillary orthognathic surgery.

06

What researchers measure

Primary outcomes

  1. The accuracy of segmental Le Fort I bone movements

    The three-dimensional linear and angular accuracy are measured as differences between the planned and postoperative positions of all repositioned bone segments. Measurements are performed on pre- and two weeks postoperative cone-beam computed tomography scans using the Mimics Innovation Suite software (Materialise NV, Leuven, Belgium). An error measure above 2 mm and/or 4 degrees is categorized as inaccurate.

    Time frame: Two weeks postoperative

  2. The stability of segmental Le Fort I bone movements

    The three-dimensional linear and angular stability are measured as differences between the short- and long-term postoperative positions of all repositioned bone segments. Measurements are performed on two weeks and two years postoperative cone-beam computed tomography scans using the Mimics Innovation Suite software (Materialise NV, Leuven, Belgium). An error measure above 2 mm and/or 4 degrees is categorized as unstable.

    Time frame: Two years postoperative

  3. The stability of the upper airway

    The stability of the upper airway space is measured as voluminal and cross-sectional area differences between the short- and long-term postoperative airway in mm3 and mm2, respectively. Measurements are performed on two weeks and two years postoperative cone-beam computed tomography scans using the Mimics Innovation Suite software (Materialise NV, Leuven, Belgium).

    Time frame: Two years postoperative

Secondary outcomes

  1. The Diagnostic Criteria for Temporomandibular Disorders Symptom questionnaire

    Has Yes/No questions for the patient, used by the clinician to diagnose according to specific diagnostic criteria. See: Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. Journal of oral \& facial pain and headache. 2014;28(1):6.

    Time frame: Preoperative and two years postoperative

  2. The Jaw Functional Limitation Scale

    JFLS-8 measures global functional limitation of the jaw. It has 8 questions scored 0-10, where 10 is the most severe level jaw limitation in the last month.

    Time frame: Preoperative and two years postoperative

  3. The STOP-BANG - Snorting, Tiredness, Observed apnea, blood Pressure, BMI, Age, Neck circumference, Gender questionnaire

    It assesses risk/likelihood of obstructive sleep apnea (OSA). It has 8 yes/no questions, and the number of yes answers are counted towards the score as follows: 0-2: low risk of OSA. 3-4: moderate risk of OSA. 5-8: high risk of OSA.

    Time frame: Preoperative and two years postoperative

  4. The Epworth Sleepiness Scale questionnaire

    Is scored by the sum of the responses to eight questions, on a scale 0-24 where 24 is the highest sleepiness. A score above 10 is considered as significant daytime sleepiness and is considered abnormal.

    Time frame: Preoperative and two years postoperative

  5. The occlusion including horizontal/vertical overlap

    The horizontal/vertical dental overlap is measured using a ruler in millimeters.

    Time frame: Preoperative, two weeks postoperative and two years postoperative

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Aug 2027, 47 months after the start.

Of 30 interventional studies with no phase under Retrognathia, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 35. This study's planned 47 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2024
First posted
Mar 7, 2024
StartActual
Sep 12, 2023
Primary completionEst.
Aug 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Jan 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06297109
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Responsible party
Sponsor
First posted
Mar 7, 2024
Start date
Sep 12, 2023
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Jan 27, 2026

Study contacts

Else M Pinholt, dr.odont.
study chair · University Hospital of Southern Denmark, Esbjerg
Alexandru Diaconu, m.sc.
principal investigator · University Hospital of Southern Denmark, Esbjerg
Michael B Holte, ph.d.
study director · University Hospital of Southern Denmark, Esbjerg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion